Does OBINUTUZUMAB Cause Off label use? 1,584 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,584 reports of Off label use have been filed in association with OBINUTUZUMAB (Gazyva). This represents 11.2% of all adverse event reports for OBINUTUZUMAB.
1,584
Reports of Off label use with OBINUTUZUMAB
11.2%
of all OBINUTUZUMAB reports
139
Deaths
239
Hospitalizations
How Dangerous Is Off label use From OBINUTUZUMAB?
Of the 1,584 reports, 139 (8.8%) resulted in death, 239 (15.1%) required hospitalization, and 43 (2.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 1,584 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
Atrial fibrillation (548)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which OBINUTUZUMAB Alternatives Have Lower Off label use Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE